Ziebold, Carolina
Evans-Lacko, Sara
Andrade, Mário César Rezende
Hoffmann, Maurício Scopel
Fonseca, Lais
Barbosa, Matheus Ghossain
Pan, Pedro Mario
Miguel, Euripedes
Bressan, Rodrigo Affonseca
Rohde, Luis Augusto
Salum, Giovanni Abrahão
de Jesus Mari, Jair
Gadelha, Ary
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.575201/2020-00)
FP7 Ideas: European Research Council (337673)
National Institute of Mental Health (R01MH120482)
Newton International Fellowship (NIF\R1\181942)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (573974/2008-0 and 465550/2014-2)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2008/57896-8 and 2014/50917-0)
Article History
Received: 20 February 2022
Accepted: 31 May 2022
First Online: 4 August 2022
Competing interests
: CZ, SEL, MCRA, MSH, LF, MGB, PMP, EM, GAS, and JJM have no conflict of interest to declare. RB reports personal fees from Torrent, Ludbeck, Ache, personal fees and non-financial support from Janssen, outside the submitted work. LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Aché, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last 3 years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr LAR have received unrestricted educational and research support from the following pharmaceutical companies in the last 3 years: Novartis/Sandoz and Shire/Takeda. Dr LAR has received authorship royalties from Oxford Press and ArtMed. AG has been a consultant and/or advisor to or has received honoraria from Aché, Daiichi-Sankyo, Torrent, Cristalia, and Janssen.